{"id":"W2562778159","doi":"10.1002/cpt.583","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP2C19</i> and Voriconazole Therapy","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Cancer Institute; Children's Mercy Hospital; National Institutes of Health; Sick Kids Foundation; Instituto de Salud Carlos III; Federación Española de Enfermedades Raras","keywords":"CYP2C19; Pharmacogenetics; Voriconazole; Medicine; Medical physics; Internal medicine; Biology; Genotype","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3670090222705866,"score_gpt":0.582856070294495,"score_spread":0.2158470480239084,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}